Filtered By:
Management: National Institute for Health and Clinical Excelle
This page shows you your search results in order of relevance. This is page number 5.
Order by Relevance | Date
Total 155 results found since Jan 2013.
NICE guidance supports new blood pressure device that can detect atrial fibrillation
The guidance backs use of WatchBP Home A, which could reduce the incidence of atrial fibrillation-related stroke by improving early detection.
The guidance also recommends that WatchBP Home A should be considered for use in people with suspected hypertension (high blood pressure) or those being screened for hypertension in primary care.
Source: NHS Networks - January 21, 2013 Category: UK Health Authors: Maria Axford Source Type: news
NICE Final Appraisal Determination on ELIQUIS®
Bristol-Myers Squibb and Pfizer Ltd. have announced that the National Institute for Health and Clinical Excellence (NICE) has issued a fast-tracked Final Appraisal Determination (FAD) recommending the oral anticoagulant Eliquis (apixaban) as an option for preventing stroke and systemic embolism, in patients with non-valvular atrial fibrillation (AF) with one or more risk factors.
Source: Pharmacy Europe - January 24, 2013 Category: Drugs & Pharmacology Source Type: news
Lucy Mangan: wanted – mother for Neanderthal baby
'Don't you long, occasionally, for something really, really interesting, something different, something overwhelmingly "other" to happen?'It's possible that the snow has driven me stir crazy. Although, as someone who, when under stress, still draws diagrams of the underground, Womble burrow-based home that she plans to build when she wins the lottery, I think that is highly unlikely. In any case, I have been seized by the idea of having another baby.Not just any old baby – I've already got one of those – but a Neanderthal baby. Earlier this week Professor George Church, a genetic researcher at Harva...
Source: Guardian Unlimited Science - January 26, 2013 Category: Science Authors: Lucy Mangan Tags: The Guardian Family Genetics Evolution Biology Parents and parenting Anthropology Features Life and style Neanderthal man Science Source Type: news
InFocus: Plans to Streamline Stroke Research in the Works
HONOLULU (MedPage Today) -- Wouldn't it be nice if a clinical trial took only months to initiate rather than years? The NIH thinks so too and has a plan to make that dream come true, deputy director Walter Koroshetz, MD, said in this exclusive InFocus interview.
Source: MedPage Today Cardiovascular - February 11, 2013 Category: Cardiology Source Type: news
New stroke prevention treatment recommended by NICE
Atrial
fibrillation (AF) is the most common
cause of irregular heart beat. It can cause the heart rhythm to become
disorganised, and on occasion too fast, leading to the inefficient pumping of
blood around the body.
Source: NHS Networks - February 28, 2013 Category: UK Health Authors: Karen Topping Source Type: news
Metformin may not reduce cardiovascular risk or all-cause mortality
Commentary on: Boussageon R, Supper I, Bejan-Angoulvant T, et al.. Reappraisal of metformin efficacy in the treatment of Type 2 diabetes: a meta-analysis of randomised controlled trials. PLoS Med 2012;9:268–82. Context The treatment of hyperglycaemia is considered as one of the tools for preventing cardiovascular disease in Type 1 and Type 2 diabetic (T2D) patients.1 2 Metformin is recommended as the first-line drug for T2D by most international guidelines (IDF.2005. http://www.idf.org, 2007. http://www.aace.com, http://www.diabetesjournals.org, http://www.nice.org.uk/CG66). The preference for metformin over other av...
Source: Evidence-Based Medicine - March 19, 2013 Category: Internal Medicine Authors: Monami, M. Tags: Geriatric medicine, Clinical trials (epidemiology), Epidemiologic studies, Drugs: cardiovascular system, Stroke, Hypertension, Diet, Ischaemic heart disease, Diabetes Online articles Source Type: research
Supporting the commissioning of anticoagulation therapy for adults
This resource supports commissioners to review how anticoagulation therapy is currently initiated, provided, monitored and reviewed in their local area with particular consideration to the introduction of the novel oral anticoagulants. NICE recommendations for rivaroxaban, dabigatran and apixaban for stroke prevention in people with atrial fibrillation and rivaroxaban for treatment of deep vein thrombosis provide people who have these conditions with more choices of medication. This will have an impact on the commissioning of anticoagulation services at a local level, with an anticipated reduction in vitamin K antagonist monitoring services.
Source: NHS Networks - May 23, 2013 Category: UK Health Authors: Maria Axford Source Type: news
Drugs to be offered to women at high risk of breast cancer
The National Institute of Health and Care Excellence (NICE) has today released updated guidelines on the care of women who are at increased risk of breast cancer due to their family history. One of the main changes to the original guidance from 2004 is that NICE now recommends drug treatment with tamoxifen or raloxifene to reduce risk of breast cancer in a specific group of women who are at high risk of breast cancer and have not had the disease.
They say that these treatments could help prevent breast cancer in about 488,000 women aged 35 years and older.
The updated guideline has also made changes to the recommende...
Source: NHS News Feed - June 25, 2013 Category: Consumer Health News Tags: Cancer Medical practice QA articles Source Type: news
Why acupuncture is giving sceptics the needle
Acupuncture has been prescribed by half of Britain's doctors, but after 3,000 clinical trials its efficacy remains unproven. So is the NHS making a grave error in supporting this ancient treatment?• Are vitamin pills a sham? Q&A with Dr. Paul OffitYou can't get crystal healing on the NHS. The Department of Health doesn't fund faith healing. And most doctors believe magnets are best stuck on fridges, not patients. But ask for a treatment in which an expert examines your tongue, smells your skin and tries to unblock the flow of life force running through your body with needles and the NHS will be happy to oblige.The govern...
Source: Guardian Unlimited Science - July 26, 2013 Category: Science Authors: David Derbyshire Tags: Culture Health Science and scepticism Features NHS Alternative medicine The Observer Source Type: news
Heparin, grad students, a clinical revolution and giving credit where it's due
The story of a grad student who overcame remarkable odds only to be denied his moment of glory, or a tale of dark deceit and devilish doings? The story of heparin is as complicated as the chemistry itselfBlood is remarkable.A liquid that carries nutrients, waste products and the ever-vigilant cells of the immune system around the body, blood rapidly turns into a solid when it leaves its veins and arteries and becomes exposed to bodily tissues or the air outside. This process of solidification – clotting, or coagulation – is executed and controlled by a complex set of reactions and interactions primarily involving the e...
Source: Guardian Unlimited Science - September 4, 2013 Category: Science Authors: Richard P Grant Tags: theguardian.com Blogposts Science Source Type: news
Euro launch of next-gen thrombectomy device announced
The European launch of a next-generation clot-removal device offering enhanced navigation through the cerebral vasculature and rapid restoration of blood flow to the brain after an ischemic stroke was announced this month at the 5th Congress of European Society of Minimally Invasive Neurological Therapy (ESMINT) in Nice, Italy. The Revive SE Thrombectomy device is by Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson.
read more
Source: Articles from MedicalDesign.com - September 16, 2013 Category: Medical Equipment Tags: Business Cardiovascular Source Type: news
Walking ‘could save 37,000 lives a year’ report claims
The benefits of walking have been reported across the UK media. The BBC reports that “walking more 'would save thousands' of lives in the UK”.
These stories have been prompted by the "Walking Works” report (PDF, 3.4MB). It provides an overview of current evidence on physical inactivity, and makes the case for encouraging more people to take up walking as a form of physical activity.
It lays out that a large proportion of the population is not meeting physical activity guidelines and that if more people did so, this could potentially save 37,000 lives a year in England. It also discusses the specific benefits o...
Source: NHS News Feed - October 7, 2013 Category: Consumer Health News Tags: Cancer Lifestyle/exercise QA articles Source Type: news
Sickle cell disease, update on management
Abstract: The article aims to provide a broad overview of sickle cell disorders emphasizing current developments in modern management. The value of neonatal screening, now universal in England, is evaluated with emphasis on the importance of effective measures to reduce the risk of pneumococcal infection. Complications of sickle cell disease are discussed individually with key points of management highlighted, stroke and the use of transcranial Doppler screening as a tool to identify high risk patients is discussed in detail.The importance of effective, safe and rapid pain relief is highlighted and reference given to new N...
Source: Paediatrics and Child Health - October 15, 2013 Category: Pediatrics Authors: Amanda Cope, P.J. Darbyshire Tags: Symposium: Haematology Source Type: research
Should I take statins?
Since 80% of cardiovascular disease is caused by lack of exercise, poor diet and smoking, it would be better to address these factors rather than pop a statinShould everyone over 50 be taking statins? asked an editorial in the Lancet last year. No, said an analysis article in last week's BMJ. Statins, in case you've escaped the hype, are drugs that block an enzyme in the liver that's needed to make cholesterol (we make it as well as eat it). Statins reduce levels of low density lipoproteins – the bad cholesterol that furs up arteries and can cause heart disease. But is there any benefit in taking a statin if yo...
Source: Guardian Unlimited Science - October 27, 2013 Category: Science Authors: Luisa Dillner Tags: The Guardian Medical research Health & wellbeing Human biology Drugs Features Life and style Science Source Type: news
Healthy BMI? 8M Britons at high risk of heart disease and diabetes despite 'normal' reading
People of African, Caribbean and Asian descent are up to six times more likely to suffer from type 2 diabetes, heart disease and stroke, NICE has warned.
Source: the Mail online | Health - January 22, 2014 Category: Consumer Health News Source Type: news
